Investing.com - Financial Markets Worldwide

Palantir, Marriott, Pfizer and BP rise premarket; Caterpillar falls

AuthorPeter Nurse
Published 05/08/2025, 12:26
Updated 05/08/2025, 12:36
© Reuters
CAT
0.33%
DD
0.69%
PFE
0.60%
MAR
0.68%
BLWV
0.00%
TSLA
-0.59%
LDOS
0.57%
BP
0.63%
INSP
0.60%
HIMS
-2.95%
PLTR
-2.58%

Investing.com -- U.S. stock futures edged higher Tuesday, continuing this week’s rebound as investors focus on more quarterly corporate results.

Here are some of the biggest premarket U.S. stock movers today:

  • Palantir (NASDAQ:PLTR) stock climbed 5.9% after the data analytics and defense software group posted its biggest quarterly revenue total since it went public five years ago, fueled by strong demand from governments and corporations for its artificial intelligence-enhanced services.

  • Caterpillar (NYSE:CAT) stock fell 3% after the heavy equipment manufacturer reported second-quarter 2025 adjusted earnings that fell short of analyst expectations, despite posting better-than-expected revenue.

  • Pfizer (NYSE:PFE) stock gained 1.8% after the drugs giant posted second-quarter earnings and revenue that exceeded analyst estimates and raised its full-year profit outlook.

  • Marriott International (NASDAQ:MAR) stock rose 6.1% after he hotel operator beat expectations for second-quarter earnings, even as it narrowed its full-year earnings outlook, flagging ongoing headwinds from federal government spending cuts and weaker business travel.

  • Tesla (NASDAQ:TSLA) stock rose 0.5%, but was still over 20% lower so far in 2025, as sales of the electric vehicle in Germany dropped over 55% in July, compared to the same month last year.

  • BP (NYSE:BP) ADRs rose 2.1% after the oil major reported second-quarter profit that beat analyst expectations, rebounding amid recent volatility in global oil and gas markets.

  • Dupont (NYSE:DD) stock rose 5% after the chemical company beat expectations on top and bottom lines in the second quarter amid continued strength in electronics, healthcare and water end-markets.

  • Leidos (NYSE:LDOS) stock soared 3.1% after the defense and technology contractor reported strong second-quarter results that exceeded analyst expectations, prompting the company to raise its full-year guidance.

  • Hims Hers Health (NYSE:HIMS) fell 12% after the telehealth company missed estimates for second-quarter revenue, as subscribers for its compounded versions of weight-loss drugs declined.

  • Inspire Medical (TASE:BLWV) Systems (NYSE:INSP) stock sank 27% after the healthcare company’s second-quarter earnings failed to impress investors.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.